Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Medicine and Dentistry
Positron Emission Tomography
100%
Polyethylene Terephthalate
64%
Tyrosine
30%
Tumor
26%
Neoplasm
25%
Positron Emission Tomography-Computed Tomography
24%
Radiation Therapy
24%
Fluorodeoxyglucose F 18
24%
Non Small Cell Lung Cancer
22%
Prostate Cancer
21%
Fluorodeoxyglucose
19%
Glucose
19%
Carbon 11
18%
Standardized Uptake Value
18%
Protein Synthesis
17%
Metastatic Carcinoma
15%
Choline
13%
Recurrent Disease
13%
Esophageal Cancer
12%
Choline C 11
12%
Fluorine-18
10%
Squamous Cell Carcinoma
9%
Primary Tumor
9%
Soft Tissue Sarcoma
8%
Laryngeal Cancer
8%
Magnetic Resonance Imaging
8%
Lymph Node Metastasis
8%
Heart Muscle Perfusion
7%
Distant Metastasis
7%
Lymph Node
7%
Cancer of Unknown Primary Origin
6%
Cancer
6%
Oral Cavity
6%
Prostatectomy
6%
External Beam Radiotherapy
6%
Sensitivity and Specificity
6%
Chemotherapy
5%
Neck
5%
Head and Neck Cancer
5%
Biopsy Technique
5%
Lung Cancer
5%
Ganglioglioma
5%
Emission Tomography
5%
Hypoxia
5%
Chemoradiotherapy
5%
Computer Assisted Tomography
5%
Keyphrases
Positron Emission Tomography/computed Tomography (PET/CT)
88%
C-11
37%
Tyrosine
34%
Protein Synthesis Rate
23%
F-18
22%
Tumor
18%
Radiotherapy
16%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
15%
Standardized Uptake Value
15%
Non-small Cell Lung Cancer (NSCLC)
14%
Fluorodeoxyglucose
12%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
12%
Prostate Cancer
11%
Choline
11%
Esophageal Cancer
9%
Head-and-neck Cancer
9%
F-18 Fluorodeoxyglucose
7%
Laryngeal Carcinoma
7%
PET Scan
7%
Lymph Node Metastasis
7%
Computed Tomography
7%
18F-fluorodeoxyglucose (18F-FDG)
7%
β-adrenoceptor
7%
SUVmax
6%
Distant Metastasis
6%
Carbon-11
6%
Primary Tumor
6%
Preoperative Staging
6%
F-18 Fluorodeoxyglucose Positron Emission Tomography
5%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
5%
Whole-body
5%
Radical Prostatectomy
5%
Human Brain
5%
Cobalt-55
5%
Laryngeal Cancer
5%
11C-choline PET
5%
